Deutsche Bank Ag\ Zentalis Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 31,931 shares of ZNTL stock, worth $95,793. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,931

Previous 23,747 34.46%

Holding current value

$95,793

Previous $97,000 20.62%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.9 - $4.57 $23,733 - $37,400	8,184 Added 34.46%	31,931 $117,000
Q2 2024 Aug 14, 2024	SELL	$4.09 - $16.13 $28,949 - $114,168	-7,078 Reduced 22.96%	23,747 $97,000
Q1 2024 May 15, 2024	SELL	$10.83 - $16.49 $130,837 - $199,215	-12,081 Reduced 28.16%	30,825 $485,000
Q4 2023 Feb 14, 2024	BUY	$9.84 - $20.13 $106,527 - $217,927	10,826 Added 33.75%	42,906 $650,000
Q3 2023 Nov 09, 2023	SELL	$19.63 - $28.29 $7.6 Million - $11 Million	-387,146 Reduced 92.35%	32,080 $643,000
Q2 2023 Aug 14, 2023	BUY	$17.41 - $30.05 $6.52 Million - $11.3 Million	374,402 Added 835.27%	419,226 $11.8 Million
Q1 2023 May 15, 2023	BUY	$16.14 - $24.94 $119,887 - $185,254	7,428 Added 19.86%	44,824 $770,000
Q4 2022 Feb 13, 2023	SELL	$18.07 - $25.6 $564,832 - $800,204	-31,258 Reduced 45.53%	37,396 $753,000
Q3 2022 Nov 14, 2022	BUY	$20.23 - $31.73 $933,128 - $1.46 Million	46,126 Added 204.75%	68,654 $1.49 Million
Q2 2022 Aug 11, 2022	SELL	$17.91 - $52.25 $190,275 - $555,104	-10,624 Reduced 32.05%	22,528 $633,000
Q1 2022 May 13, 2022	SELL	$41.58 - $80.89 $76,257 - $148,352	-1,834 Reduced 5.24%	33,152 $1.53 Million
Q4 2021 Feb 11, 2022	BUY	$66.92 - $84.79 $79,166 - $100,306	1,183 Added 3.5%	34,986 $2.94 Million
Q3 2021 Nov 04, 2021	BUY	$46.83 - $73.5 $535,641 - $840,693	11,438 Added 51.14%	33,803 $2.25 Million
Q2 2021 Aug 11, 2021	BUY	$37.41 - $62.25 $31,087 - $51,729	831 Added 3.86%	22,365 $1.19 Million
Q1 2021 May 13, 2021	SELL	$35.69 - $52.72 $65,776 - $97,162	-1,843 Reduced 7.88%	21,534 $934,000
Q4 2020 Feb 16, 2021	BUY	$31.71 - $57.97 $542,938 - $992,562	17,122 Added 273.73%	23,377 $1.21 Million
Q3 2020 Nov 12, 2020	BUY	$27.03 - $47.97 $27,543 - $48,881	1,019 Added 19.46%	6,255 $205,000
Q2 2020 Aug 13, 2020	BUY	$23.2 - $54.8 $121,475 - $286,932	5,236 New	5,236 $252,000

Others Institutions Holding ZNTL

# of Institutions

142

Shares Held

67.9M

Call Options Held

48.5K

Put Options Held

89.6K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $171M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account